Aids research (basic)

Ended Definitive Contract Awarded Sep 30, 2008 Last action Dec 27, 2017

Contract number: HHSN272200800063C
Awardee: VGX Pharmaceuticals, LLC UEI GK83K7A8Z9M9
Awarding agency: National Institute of Allergy and Infectious Diseases National Institutes of Health, Department of Health and Human Services
Obligated: $24,297,434

Award facts

Opportunity: "Development of Improved DNA Vaccines and Electroporation Delivery Devices for HIV Prophylactic HIV Vaccines" Award Notice · Posted Sep 26, 2008
Contract value 100% obligated: $24,297,433.92 Current and potential, with all options
Completion date 100% complete: Sep 30, 2018 Current and potential, with all options
NAICS code: 541711 Research and Development in Biotechnology
PSC: AN81 R&D- Medical: Aids Research (Basic Research)
Set-aside: No set-aside
Competition: Full and Open Competition · 2 offers Negotiated Proposal / Quote
Pricing: Cost No Fee
Place of performance: Penllyn, PA 19422, USA

Award details come from SAM.gov/FPDS.

Transactions

Action	Obligated	Date
Other Administrative Action 13	$0	Dec 27, 2017
Other Administrative Action 12	$0	Nov 28, 2017
Funding Only Action 11	-$881	Apr 17, 2017
Funding Only Action 10	-$5,641	Mar 9, 2016
Funding Only Action 9	-$0	May 21, 2015
Other Administrative Action 8	$0	Sep 29, 2014
Exercise an Option 7	$1,312,685	Aug 28, 2013
Exercise an Option 6	$2,529,017	Aug 21, 2012
Vendor DUNS or Name Change - Non-Novation 5	$0	Aug 1, 2012
Exercise an Option 4 · Development of improved DNA vaccines and electroporation delivery devices for HIV prophylactic HIV	$3,342,566	Sep 21, 2011
Funding Only Action 3 · The purpose of this modification is to provide funds to cover the fiscal year 2008 and 2009 cost rate adjustments and to update university of pennsylvania…	$624,181	Jan 18, 2011
Exercise an Option 2 · Development of improved DNA vaccines and electroporation delivery devices for HIV prophylactic HIV vaccines	$5,258,144	Sep 29, 2010
Exercise an Option 1	$6,573,776	Sep 23, 2009
Original award	$4,663,588	Sep 26, 2008

Show all 14

Quick answers

Who was awarded contract HHSN272200800063C?

HHSN272200800063C was awarded to VGX Pharmaceuticals, LLC by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 30, 2008.

How much is contract HHSN272200800063C worth?

The government has obligated $24,297,434 on HHSN272200800063C.

Was contract HHSN272200800063C competed?

The extent of competition for HHSN272200800063C was full and open competition. The government received 2 offers.

On GovTribe

See this award's full record

Every transaction and funding action
The awardee's other awards and teaming partners
Similar awards and recompete opportunities
Ask GovTribe AI about this award

Try for free Login